Loren Data Corp.

'

 
 

COMMERCE BUSINESS DAILY ISSUE OF FEBRUARY 5,1999 PSA#2277

311th HSW/YAK, 8107 13th St, Brooks AFB, TX 78235-5218

65 -- REQUEST FOR INFORMATION (RFI) SYNOPSIS ANNOUNCEMENT FOR THE COMMERCE BUSINESS DAILY: MEDICAL EQUIPMENT, AEROMEDICAL EVACUATION, OXYGEN GENERATING SYSTEMS, COMPRESSORS, CRYOGENICS SOL F41624-99-R-1002 DUE 030499 POC David M. Foote, (210) 925-6831, Michael J. Nannery, (210) 536-4559, or Larry Looper, (210) 536-4458 WEB: RFP not applicable, UNDER CONSTRUCTION. E-MAIL: To contact contract specialist, see e-mail address, davfoote@ldgate1.kelly.af.mil. This is not a notice of solicitation. The 311th Human Systems Wing at Brooks AFB is seeking information on the commercial capabilities and costs of medical equipment, technologies or systems that support the Air Force Medical Service mission to provide Patient Therapeutic quality oxygen in Aeromedical evacuation (AE) aircraft, C-5, C-130, KC-10, and KC-135. Background -- The current system used to support patient oxygen requirements in the Air Force Aeromedical evacuation system (AES) is the Patient Therapeutic Liquid Oxygen System (PTLOX). This system depends upon the availability of liquid oxygen (LOX) and is labor intensive to support and maintain. Changes in aircraft oxygen systems from LOX dependent systems to On-Board Oxygen Generating Systems (OBOGS), as well as changes in operational employment of forces has made it increasingly difficult to find LOX to support the PTLOX systems in forward deployed areas. Additionally, as fewer airframes depend upon LOX, the ability to maintain these systemsin garrison and while deployed continues to diminish. Unlike the PTLOX system, current OBOGS do not provide 100 percent oxygen. Integration of OBOGS into existing airframes easily meets flight crew oxygen requirements. However, many patient conditions, as well as international standards for patient care, require the availability of 100 percent oxygen for therapeutic purposes. Currently, improved oxygen system components and packaging are needed that will directly meet AES and airlift power, weight, and size constraints, and deliver 100 percent oxygen to satisfy operational requirements. Information on technologies that support on-board oxygen generation is being sought. In relation to the provision of on-board AES missions, either of two (2) separate concepts of operation is acceptable: (1) Single piece system should have the capability to produce, store and deliver therapeutic oxygen in a single, integrated system that is man-portable and capable of integration onto all current and potential airframes usedin fixed-wing patient evacuation. Equipment should have the following characteristics: (a) Human factors: portable, compact, and compatible with use in aircraft, with the complete system less than 300 pounds total when filled to capacity and not exceeding 2 ft. x 3 ft. x 5 ft. (2 ft. being critical -- the width of the patient litter); (b) Oxygen Generation -- minimum 33 (45 preferred) liters per minute of gaseous oxygen at 50 psig for 16 hours; (b) Oxygen Generation -- minimum 33 (45 preferred) liters per minute of gaseous oxygen at 50 psig for 16 hours; (c) Oxygen Distribution -- 3 distribution outlets required, capability to fill oxygen tanks, desired; (d) Oxygen Quality > or equal to 99.0 percent purity; (e) Emergency Operation -- must maintain oxygen delivery during power termination for 2 hours minimum (4 hours desired); (f) Operating Temperatures -- operate in temperatures of -24 to +140 degrees Fahrenheit; (g) Electrical -- operate on worldwide hospital and aircraft AC current, not to exceed 115-220 VAC, 50-400 HZ, 15 amps (10 amps maximum preferred), 5,000 watts (total), 28 VDC; and (h) Certification -- Food and Drug Administration (FDA) certification of conforming to FDA requirements for medical devices and U.S. Pharmacopoeia (USP) requirements for hospital-grade oxygen. (2) Two piece system should have the capability to produce, store and transfer therapeutic oxygen to a "fly-away" component, which would be used to deliver the therapeutic oxygen to meet patient requirements. Transfer from production system to delivery system should be automated. Equipment should have the following characteristics: (a) Human Factors: Fly-away portion must be portable, compact, and compatible with use in aircraft and weigh less than 300 pounds when filled to capacity, and not exceeding 2 ft. x 3 ft. x 5 ft; Ground-based portion must be mobile and easily transportable; (b) Oxygen Generation -- minimum 33 (45 preferred) liters per minute of gaseous oxygen at 50 psig for 16 hours; (c) Oxygen Distribution: Flyaway unit must have minimum of three distribution outlets; ground unit must fill one flyaway unit (three simultaneously, desired) and have capability to fill high-pressure oxygen tanks (desired); (d) Oxygen Quality: > or equal to 99.0 percent purity; (e) Emergency Operation- Fly-away unit must maintain oxygen delivery during power termination for 2 hours minimum (4 hours desired); (f) Operating Temperatures -- operate in temperatures of -24 to +140 degrees Fahrenheit; (g) Electrical -- operate on worldwide hospital and aircraft AC current not to exceed 115-220 VAC, 50-400 HZ, 15 amps (10 amps preferred), 5,000 watts (total), 28 VDC; and (h) Certification -- Food and Drug Administration (FDA) certification of conforming to FDA requirements for medical devices and U.S. Pharmacopoeia (USP) requirements for hospital-grade oxygen. Responses for commercially available or developmental equipment should be submitted. If commercially available items were procured by the Air Forceat a future date, minimal development funding is expected to be required. Funding that would be available for equipment acquisition would be for field testing to ensure reliability, maintainability, ruggedness (vibration, drop, etc.), and environmental (heat, cold, humidity, etc.), and compatibility to bring equipment into compliance with those requirements. Submissions should identify how the equipment is capable of meeting the above specifications. Responses should include: (1) technical specifications that include all performance capabilities and required interfaces, i.e., power, environmental, etc.; (2) results of all testing that has been accomplished to date and any planned future testing, along with a schedule to include expected/actual performance/capability, reliability, maintainability and in-flight use; (3) current production rates of the equipment and approximate delivery schedule; (4) logistics concepts for repairing and maintaining the equipment; (5) any cost data available for the equipment including unit, maintenance and operational life cycle, either projected or actual; (6) manufacturing standards of the company; and (7) current users of equipment. Capability statements, excluding resumes, shall be submitted to 311 HSW/YAMA, 8107 13th St, Brooks AFB, TX 78235-5218, within 30 days of publication of this notice. This is a sources sought synopsis. This is not a request for proposal and in no way commits the Government to an award of contract. Reimbursement of any cost regarding the preparation of proposals or bids will not be made. TECHNICAL QUESTIONS MAY BE DIRECTED TO MR. LARRY LOOPER, 311 HSW/XRS, (210) 536-4458. All non-technical and contractual questions should be addressed to 311 HSW/YAMA, David M. Foote, Contract Specialist, (210) 925-6831 or Michael J. Nannery, Contracting Officer, (210) 536-4559. Posted 02/03/99 (W-SN294323). (0034)

Loren Data Corp. http://www.ld.com (SYN# 0315 19990205\65-0006.SOL)


65 - Medical, Dental and Veterinary Equipment and Supplies Index Page